10 June 2021| Epidemiology, medical research, innovation: a day to take stock of the advances underway thanks to Epicentre
Epicentre's Scientific Day invites you to discover the range of activities and its epidemiology and research projects in humanitarian situations. This year, this plunge into the heart of Epicentre will take place on 10 June in a virtual setting due to the health situation. Moreover, the COVID-19 pandemic will be the subject of a session as Epicentre has been working since the beginning to assess the situation in MSF intervention sites and has also launched sero-prevalence studies among people in great precarious situations in France and some areas of the African continent to evaluate the real impact.
Despite the COVID pandemic, other studies, notably on tuberculosis, malaria, ebola, antibiotic resistance, post-abortion complications, trypanosomiasis and snake bites, have continued, and the results will be presented to you during the day.
Working alongside MSF for more than 30 years, Epicentre's teams have been conducting studies whose results should lead to medical practices changes. One session will be devoted to vaccination and the possibilities offered by fractional dose to improve access to vaccines against yellow fever and pneumococcal infections, for example.
Given the changing international healthcare landscape and the higher prevalence of chronic non-communicable diseases such as cancer, one session will be devoted to Epicentre's studies in the field of oncology, an area of MSF's developing operational policy.
And to conclude, we invite you to a session on innovations in digital health and their impact on epidemiologists' daily work. To make medical practices evolve, it is also necessary to integrate the latest tools available: mobile phones, dashboards, GPS, etc.
Epicentre makes every effort to provide information and practical solutions to improve access to quality healthcare for populations living in unstable conditions or insufficient access to care. This objective is based on our intangible link with MSF, our experience, and our team's expertise.
We will soon communicate the detailed program of this day, which will allow you to dive into the latest advances made by Epicentre's epidemiologists and researchers. You can already contact us for more information.